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ABSTRACT 
 
The purpose of this study was to evaluate the treatment effect of an antioxidant-
essential oil gel on orthodontic patients with generalized gingivitis. The gel contains the 
essential oils menthol and thymol, and the antioxidants ferulic acid and phloretin.   
Thirty patients from the Texas A&M University Baylor College of Dentistry 
orthodontic clinic were screened for gingivitis, and randomly allocated into treatment 
and placebo-control groups.  Each patient was evaluated at three orthodontic treatment 
visits (T1, T2, and T3).  A periodontal examination, including probing depths (PD), 
bleeding on probing (BOP), gingival index (GI), and plaque index (PI) was performed at 
each visit.  Between T1 and T2, patients were instructed to apply a topical gel (active or 
placebo) to their gingiva twice daily, after brushing.  From T2 to T3 patients were 
instructed to discontinue use of the gel.   
The treatment group showed statistically significant (p<.05) reductions of BOP (-
13.6 percentage points) and GI (-0.14) between T1 and T2, and significant increases in 
BOP (13.3 percentage points) and GI (0.14) between T2 and T3. Except for an increase 
in the GI between T2 and T3, the control group showed no significant changes in BOP 
or GI over time.  The only other significant changes that occurred pertained to the 
treatment group, which showed significant increases in PD (0.08mm) and PI (0.18) 
between T2 and T3.  
Application of a topical antioxidant-essential oil gel is an effective means of 
reducing inflammation in orthodontic patients with gingivitis.  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Gingivitis is among the most common pathologies affecting the population, with 
a reported prevalence of over 50% and ranging up to 100%.1-3 Gingivitis is common in 
all age groups, but some patterns are related to age.  Around the time of puberty, the 
prevalence greatly increases, peaking between the ages of 9-14,3, 4 which should be of 
special interest to orthodontists considering the high number of adolescents in most 
orthodontic practices.  From age 11-17 there is another trend to decrease in frequency, 
with a subsequent increase throughout the adult years; in the sixth decade, prevalence 
nears 100%.3  Most commonly, gingivitis is associated with poor oral hygiene in both 
non-orthodontic and orthodontic patients.  In conjunction with poor oral hygiene, 
increased mechanical plaque retention associated with fixed orthodontic appliances is 
one of the major reasons for high rates of gingivitis in orthodontic patients.5, 6  More 
recently, oxidative stress, and cytotoxic effects related to materials in fixed appliances 
and bonding agents have been implicated as factors causing gingival inflammation.7-10   
Several modalities are available for treatment of gingivitis, including proper oral 
hygiene instructions, various dentifrices, and mouthwashes.11, 12  The current gold 
standard is use of chlorhexidine mouth rinse, with use of essential oil mouth rinses also 
providing effective therapy.13   There is also a developing body of evidence to suggest 
that use of antioxidants may be helpful in the treatment of gingivitis.14-16  
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This review of the literature will first describe gingivitis and the biology of 
gingivitis. Then it will explore the relationship of orthodontics, gingivitis, and oxidative 
stress, including possible sequelae of gingivitis in orthodontic patients.  Finally, a 
rationale for the use of antioxidants as a treatment modality for gingivitis in orthodontic 
patients will be presented. 
 
Biological Basis of Gingivitis and Inflammation 
 
 Bartold et al provide a concise review of the changes in gingival tissues during 
inflammation.17  The underlying factor for all gingivitis is accumulation of plaque as the 
inciting agent.  With this accumulation, an inflammatory response is initiated that 
involves numerous cell types, pathways, and molecular signals.  The first line of defense 
is the junctional epithelium, which resides in the gingival sulcus; these cells respond to 
the insult with release of various cytokines, including interleukins 1 and 8 (IL-1 and IL-
8), which are involved in neutrophil recruitment.  Intercellular spaces in the junctional 
epithelium also begin to widen, allowing for movement of the inflammatory exudate into 
the gingival sulcus.  At this point, if the inflammatory stimulus remains, neutrophil 
migration will continue along with increases in other immune cell populations, including 
polymorphonuclear lymphocytes (PMN) and T-lymphocytes.  With prolonged 
inflammation, cytotoxic by-products of the inflammatory response result in apical 
migration of the junctional epithelium as the regeneration of new cells is insufficient to 
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out-pace the amount of tissue destruction; this denotes the earliest phase of pocket 
formation. 
 In addition to changes in the epithelium, the underlying connective tissue is also 
heavily involved in the inflammatory response. The major immune cell components 
within the connective tissue are PMNs, T-lymphocytes, and neutrophils.  Platelet derived 
growth factor (PDGF), transforming growth factor-β (TGF-β), prostaglandin-E2 (PGE2), 
interferon-γ, tumor necrosis factor-α (TNF-α), Il-1, IL-6 and IL-8 are some of the major 
signaling molecules released from inflammatory cells that affect behavior of fibroblasts 
in the connective tissue matrix.  These molecules lead to varied responses, which include 
induction of mitosis (PDGF), increased collagen and proteoglycan production (TGF-β), 
increase in collagenase production (TNF-α, IL-1), inhibition of collagen synthesis (PGE-
2, interferon-γ, TNF-α), and other processes leading to matrix degradation (IL-1, IL-6, 
IL-6, IL-8, interferon-γ).  Interferon-γ, IL-1 and Il-6 also stimulate cell-to-cell adhesion 
between fibroblasts and neutrophils.  These interactions are shown to increase 
cytotoxicity through the generation of oxygen-derived free radicals.  
 In summary, the junctional epithelium of the gingival sulcus is the first responder 
when confronted with bacterial challenge.  This can lead to involvement of the 
underlying connective tissue and a prolonged inflammatory response, with destruction of 
tissue, if the inciting agent is not removed. 
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Increased Inflammation due to Orthodontic Appliances 
 
Orthodontic appliances have been consistently linked to increased inflammation 
of the gingiva.  Reasons cited include mechanical plaque retention, changes in the 
composition of oral microflora following placement of orthodontic appliances, and 
oxidative cytotoxic byproducts originating from orthodontic materials. 
Zachrisson and Zacrhisson evaluated the condition of the gingiva during 
orthodontic treatment.5  Their study included 49 patients treated with edgewise 
appliances, and a control group of 53 subjects matched for age and sex from the local 
schools. Measurements were taken at the buccal and mesial surfaces of the upper right 
first molars, second premolars, canines, and central incisors.  Patients in the treatment 
group typically exhibited generalized moderate gingivitis within one to two months after 
appliance placement. This change was noted despite low plaque indices, which was due 
to intensive oral hygiene instruction. Gingival index scores in the treatment group 
(interproximal, 1.78 ± 0.28; buccal, 1.33 ± 0.37) were higher than those of the control 
group (interproximal, 1.23 ± 0.36; buccal, 0.92 ± 0.49) even though the plaque indices of 
the treatment group were lower than scores in the control group (0.49 ± 0.41 vs. 0.68 ± 
0.61). 
Kloehn and Pfeifer also evaluated the periodontal condition of orthodontic 
patients, examining 50 consecutive cases before, during, and following orthodontic 
treatment.18  Prior to treatment, a periodontal exam was performed.  This exam was 
repeated every 3 months during treatment, 48 hours after removal of appliances, and 
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again four months later.  Patients were also provided with oral hygiene instructions 
throughout the course of treatment.  Using Russell’s periodontal index (lower scores 
indicate periodontal health), the number of patients scoring “0” decreased from 20% to 
10% after eight months of treatment.19  Patients were also noted to have an increase in 
gingival hyperplasia during treatment, especially in the premolar and molar regions.  
Evaluation of oral debris using Greene and Vermillion’s method showed a slight 
decrease in plaque after initiation of treatment.20  Following removal of appliances, the 
subjects’ periodontal condition improved, and no detrimental effects were noted as a 
result of orthodontic treatment.  The authors attributed the increased inflammation 
during treatment to the presence of orthodontic materials in the mouth, including bands, 
cements, and the proximity of the wires to the tissue in the posterior regions. 
In another study looking strictly at the second molars, gingivitis developed 
within one month of placement of either a bonded tube or a cemented band.6  While the 
level of gingival inflammation was higher with cemented bands than with bonded tubes, 
both groups showed higher gingival index scores following placement of the orthodontic 
appliances than untreated controls. They also showed elevated plaque index scores. The 
authors cited increased mechanical plaque retention of the orthodontic attachments and 
their impingement on the proximity of gingival tissues as possible reasons for the 
findings. 
Sixty patients were enrolled in a study to evaluate the changes that occur in the 
subgingival microbiota during orthodontic treatment.21  Experimental subjects were 
recruited from patients who were to receive orthodontic treatment; control group 
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subjects did not receive orthodontic treatment (n=30 for both groups).  Patients in the 
experimental group were evaluated prior to appliance placement and 3 months following 
appliance placement; subjects in the control group were evaluated only once.  The 
results corroborated previous findings of increased bleeding on probing (baseline 
experimental group, 11.6 ± 14.6%; 3 month experimental group, 19.4 ± 21.9%; control 
group, 4.4 ± 8.6%), higher gingival index (baseline experimental group, 0.2 ± 0.3; 3 
month experimental group, 0.4 ± 0.5; CG, 0.1 ± 0.2), and a higher plaque index (baseline 
experimental group, 7.0 ± 5.0%; 3 month experimental group, 9.2 ± 5.0%; CG, 5.1 ± 
2.6%) following appliance placement when compared to baseline initial presentation and 
compared to the control group.  Additionally, they showed a change in the make-up of 
the plaque bacteria, with elevated levels of Porphyromonas gingivalis, Prevotella 
intermedia/Prevotella nigrescens, Tannerella forsythia and Fusobacterium species. The 
experimental group also demonstrated the presence of superinfecting bacteria that can 
lead to periodontitis. 
A similar study evaluated patients 1 week, 3 months, and 6 months following 
placement of fixed appliances. The pathogenic bacteria Tannerella forsythia and 
Prevotella nigrescens were significantly increased, while others were increased but did 
not show statistically significant differences between the treated and control groups.22 
 
 
 
 
 7 
 
Oxidative Stress and Inflammation in Periodontal Tissues 
 
 Reactive oxygen species (ROS) are involved in tissue damage through a variety 
of different mechanisms, including DNA damage, lipid peroxidation, protein damage, 
oxidation of enzymes, and stimulation of pro-inflammatory cytokine release.23   
ROS are found in all living cells as a result of metabolism, and can also be introduced to 
the cells via interaction with compounds surrounding or near the cells.  As oxidative 
stress increases, and if self-contained antioxidant mechanisms are unable to neutralize 
the build-up of ROS, cellular damage can result.9  
Wei et al established links between increased oxidative stress and periodontal 
disease.7  Nineteen patients with periodontal disease were compared to 8 control subjects 
that were free of periodontitis.  Gingival crevicular fluid from both groups was examined 
for several markers of oxidative stress, including glutathione peroxidase, lactoferrin, 
myeloperoxidase and interleukin-1β.  The disease group demonstrated higher levels of 
each of these substances, and their levels were positively correlated with the plaque 
index, gingival index, probing depth, and probing attachment level.  The authors 
concluded that the levels of these substances could result in damage from reactive 
oxygen species. 
A similar study by Patel et al confirmed the higher level of oxidative insult 
present in periodontal disease.  Sixty subjects were recruited into 3 groups; healthy, 
gingivitis, and periodontitis.10  Gingival crevicular fluid from each group was analyzed 
for plasma glutathione peroxidase, a marker for oxidative stress.  The levels of plasma 
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glutathione peroxidase were positively correlated with the severity of periodontal 
disease, with the healthy group showing the lowest levels, and the periodontitis group 
showing the highest levels. 
 Associations have also been found between decreased levels of salivary 
antioxidant capacity and periodontal disease.  Sculley and Langley-Evans evaluated 129 
patients during a routine dental check-up; in addition to analyzing each patient’s salivary 
antioxidant capacity, they characterized each patient’s periodontal condition based on 
the Community Periodontal Index of Treatment Needs system.24  Patient’s with lower 
antioxidant capacity, specifically lower levels of urate, scored lower on the index.  The 
authors concluded that there is an association between reduced salivary antioxidant 
capacity and increased oxidative damage in the periodontium. 
 
Sequelae of Gingivitis in Orthodontics 
 
With the increased risk and severity of gingivitis in orthodontic patients, it is 
important to understand the possible sequelae that go along with this, and what can occur 
with prolonged inflammation.  
Gingivitis by itself poses certain risks to periodontal health, which can become 
amplified by fixed appliances.  While it has been suggested that the inflammatory 
changes, including increased gingival index and pocket depths,  are largely transient 
during orthodontic treatment,5, 6 the fact remains that prolonged inflammation can have 
permanent detrimental effects on the periodontium. 
 9 
 
If the inflammation has progressed beyond gingivitis to periodontitis with bony 
involvement, the implications can be quite serious in regards to attachment loss.  If the 
subgingival plaque and calculus are not controlled, any tooth movement may accelerate 
loss of attachment.25  Animal studies have shown that tooth movement into an infrabony 
pocket will result in additional bone loss compared to control teeth with a pocket and no 
tooth movement.26, 27 
Another issue that may arise with gingivitis during orthodontic therapy is 
gingival hyperplasia.  Consistently poor oral hygiene may lead to gingival hyperplasia, 
especially in the lower incisor region.  This can be difficult to differentiate from 
superficial fibrosis, and should be investigated to evaluate if there is any evidence of 
attachment loss, which can occur in severe cases of gingival hyperplasia.25, 28  Much of 
the risk from gingival hyperplasia comes from the environment that is created by 
increasing pocket depth, and in susceptible patients may lead to periodontitis.  Palomo et 
al also argued that it is impossible to differentiate between a relatively innocuous 
pseudopocket and gingival hyperplasia that will lead to actual attachment loss.28 
Zachrisson and Alnaes evaluated a group of 51 patients for attachment loss at 
four sites (first molar, second premolar, canine, central incisor) during orthodontic 
treatment.29 When compared to non-treated controls, the patients exhibited small 
(0.30mm mean), but significant attachment loss at 3 of the 4 selected sites (second 
premolar, canine, central incisor).  While they were unable to specifically determine 
what the cause of the attachment loss was, they emphasized the potential role of 
gingivitis because of its influence on the periodontium.  They also cited examples from 
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an earlier study by Rateitschak et al,30 which showed some orthodontic cases with 
evident gingivitis and the beginning of apical migration of the pocket epithelium. 
 It is evident that the inflammation occuring with gingivitis is conducive to 
periodontal breakdown if left untreated.  Additionally, the inflamed oral environment 
that accompanies gingivitis makes it more difficult to keep the enamel clean and healthy.  
This can lead to white spot lesions and caries.  Tanner et al evaluated a sample from the 
Boston Children’s Hospital dental department.31  Sixty subjects were recruited 
sequentially; 30 with white spot lesions, and 30 without.  They described a strong 
correlation between gingivitis and the detection of enamel white spot lesions in their 
sample.  Patients with white spot lesions showed a higher mean gingival index, but did 
not differ in plaque index, compared to those without lesions. 
  
Cyotoxicity, Oxidation, and Inflammation Associated With Orthodontic Materials 
 
Many of the materials commonly used in orthodontics are known to increase 
oxidative stress and are linked to other undesirable processes.  Iron, copper, chromium, 
and vanadium undergo a redox cycle that generates free radicals32, and  alumina 
ceramics have shown increased chromosomal anomalies and weak genotoxicity.33 
Several studies have confirmed these types of findings with specific use of orthodontic 
products in-vitro.   
Spalj et al evaluated several different types of archwires to determine the amount 
of oxidative stress induced by each.9  In their in-vitro study, mouse fibroblast cells were 
 11 
 
exposed to the different types of archwires.  After 48 hours the viability of the cells was 
recorded and the cells’ DNA were analyzed for oxidative damage.  The results showed 
no acute toxicity to the cells, but there was a statistically significant difference between 
some metals.  Nickel-titanium resulted in the lowest cell viability, and was significantly 
lower than the negative and absolute control, and all archwires except titanium-
molybdenum.  Nickel-titanium also showed the highest level of oxidative stress; higher 
than all wires and controls (P<0.05). 
Buljan et al exposed different types of brackets to simulated intraoral conditions 
to determine levels of cell viability and increased oxidative stress.34  Seven different 
types of brackets (stainless steel, monocrystalline sapphire ceramic, aluminum 
oxide/cobalt-chrome, aluminum oxide/nickel-cobalt and rhodium, polyurethane, 
stainless steel/nickel-titanium, and polycarbonate stainless steel) were placed in artificial 
saliva and stored for 30 days at 37°C.  Additionally, a positive control (H2O2) and 
negative control (artificial saliva only) were stored under the same conditions.   
Following this phase, the artificial saliva that had been exposed to the various brackets 
was placed on murine fibroblast cell cultures, and the effects on cell viability and 
oxidative damage were evaluated. 
The positive controls exhibited the lowest cell viability (89.93±3.07%), and was 
significantly different from all brackets except the polyurethane (94.93±3.03%).  
Monocrystalline sapphire ceramic showed the greatest amount of cell number increase, 
but was not significantly greater than that seen in other brackets or the positive control 
group.  The highest levels of oxidative stress were noted for the stainless steel 
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(1.44±0.36 8-OHdG, ng/ml) and stainless steel/nickel-titanium brackets (1.42±0.15).  
However, all brackets with the exception of the monocrystalline sapphire ceramic 
(1.09±0.42), demonstrated higher oxidative stress than the positive control (1.10±0.50). 
The authors concluded that all brackets, regardless of the material properties, are 
a source of in-vitro oxidative stress, with stainless steel and polyurethane being the least 
biocompatible.  Conventional ceramic brackets showed the highest level of 
biocompatibility. 
An earlier study by Grimmsdottir et al investigated the cytotoxic potential of 
orthodontic materials by means of an agar overlay test with mouth fibroblast cells.8  
Materials were evaluated based on the presence or absence of zones of lysis surrounding 
the orthodontic material, and on the extent of the zones.  None of the archwires induced 
cell lysis, despite high levels of cytotoxic nickel.  However, devices containing high 
levels of brazing material, such as molar bands, face bows, and some brackets, showed 
high levels of cytotoxicity, with large areas of cell lysis surrounding them. 
 
Essential Oils and Treatment of Gingivitis 
 
 The use of essential oils is well documented in the literature, and they have been 
proven effective in reducing gingivitis in orthodontic patients as well as the general 
population.35, 36  Gunsolley et al carried out a systematic review which concluded that 
use of essential oil mouth rinses provides improved oral hygiene and reduced plaque and 
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gingivitis.  Additionally, Tufecki et al showed that use of Listerine, an essential oil 
mouth rinse, reduces the amount of plaque and gingivitis in orthodontic patients.35 
 
Antioxidants in Prevention of Plaque and Inflammation 
 
 With the links between oxidative stress and inflammation becoming more clearly 
defined, promising research is being conducted on the use of antioxidants to control 
inflammation.  Sendamangalan et al looked specifically at several polyphenolic 
compounds, including gallic acid, tannic acid, quercetin and salicylic acid.14  Each of 
these compounds was tested for antimicrobial capability against Streptococcus mutans 
and also for their antioxidant capacity.  Of these compounds, tannic acid showed the 
highest antimicrobial activity, and also a high antioxidant capability.  However, the high 
antimicrobial capability of tannic acid results in cytotoxicity if the concentration is too 
high, making it difficult to obtain a high antioxidant capacity at safe levels intraorally. 
Salicylic acid showed the lowest level of antimicrobial activity and the weakest 
antioxidant capacity.  Gallic acid and quercetin showed high levels of antioxidant 
capacity in addition to good antimicrobial capability, making them better candidates for 
use intraorally.   
The same authors evaluated the effects of these polyphenolic compounds against 
specific enzymes involved in the biofilm formation of dental plaque: glucosyl and 
fructosyl transferase.15  These enzymes aid in the conversion of sucrose to glucose and 
fructose, and also in the process of polymerizing glucose and fructose to glucans and 
 14 
 
fructans.  These glucans and fructans chains are integral to the adhesion of plaque 
bacteria to the tooth structure.  Ascorbic acid (the positive control) and quercetin showed 
a 45% inhibition of these enzymes compared to a negative control. Quercetin also 
showed a 75% reduction in biofilm formation compared to 76% reduction for ascorbic 
acid.  Gallic acid only showed a 15% reduction in enzyme capacity, but an 82% 
reduction in biofilm formation, suggesting that the biofilm inhibition is accomplished by 
means other than enzyme inhibition.  Tannic acid reduced enzyme activity by 32% and 
biofilm formation by 66%.  Salicylic acid showed the lowest inhibition of enzyme 
activity and the lowest reduction in biofilm formation. 
Other research on polyphenols has been performed using substances extracted 
from the Lonicera caerulea fruit (sweetberry honeysuckle).16  Human gingival 
fibroblasts were harvested from healthy donors during third molar extractions.  Cells 
were cultured, then exposed to E. coli lipopolysaccharides (LPS) to induce reactive 
oxygen species/oxidative damage and inflammation.  Polyphenolic fractions of L. 
caerulea (PFLC) were also added to the samples to evaluate its antioxidant capability.  
Intracellular glutathione (GSH, an antioxidant already present in cells) was measured for 
its level of depletion. Levels of pro-inflammatory cytokines and enzymes such as IL-1α, 
IL-1β, IL-6, IL-8, TNF-α, iNOS, and COX-2 were measured to gauge the inflammatory 
response of the cells. The amount of lipid peroxidation was also measured to directly 
evaluate antioxidant capacity. Results of the study showed no harmful effects from the 
PFLC; no visible effects of cytotoxicity were observed on the control samples exposed 
to the PFLC.  In the absence of LPS, PFLC had no effect on GHS levels. In LPS exposed 
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cells, the levels of GSH were markedly decreased. However, when treated with PFLC, 
cells that had been exposed to LPS showed less depletion of GSH, suggesting good 
antioxidant capacity of the PFLC.  When directly measured, the amount of lipid 
peroxidation was greatly decreased by applying PFLC to LPS exposed cells.  Levels of 
oxidation in PFLC treated cells approached the level seen in cells that were not exposed 
to LPS.  In addition to antioxidant capacity, effects were also seen in the evaluation of 
the inflammatory mediators.  Application of PFLC alone decreased IL-6, but had no 
effect on the level of IL-1β or TNF-α.  Exposure to LPS generated increases in IL-1β, 
TNF-α, and IL-6 compared to untreated cells.  In LPS-exposed cells, treatment with 
PFLC at the highest level (50 μg ml-1) showed marked reductions in IL-1β, TNF-α, and 
IL-6. Western blot analysis showed that PFLC treated cells also showed a reduction in 
COX-2 expression (greatest effect at 25 μg ml-1), but had no effect on iNOS expression 
at any concentration. 
 Ferulic acid and phloretin are two other phenolic antioxidant compounds that 
have been shown to have anti-inflammatory capabilities.37, 38  Phloretin is one of several 
polyphenolic compounds found in apples, and ferulic acid is available in many common 
food items, including wheat, oranges, tomatoes, carrots, and sweet corn. Jung et al 
showed reduced expression of NF-κB, and other pro-inflammatory genes in various 
cultured cancer cell lines when treated with phloretin.38  Another in-vitro study using 
splenocytes showed a reduction in the levels of inflammatory mediators such as 
prostaglandin E2 and tumor necrosis factor-alpha with the introduction of ferulic acid 
and its metabolites.39 
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There is also research regarding the use of monusaturated fatty acids (MUFA) in 
the treatment of periodontal disease. MUFAs have been shown to decrease low-density-
lipoprotein oxidation,40 which partially led to the investigation of these compounds in 
combatting periodontal disease.  There is recent evidence to support the acceleration of 
periodontal disease by lipid peroxidation, caused specifically by Aggregatibacter 
actinomycetemcomitans.41   Hasturk et al evaluated the effects of one such MUFA, 1-
tetradecanol complex (1-TDC) in experimentally induced periodontitis in rabbits.42 
Fifteen animals were randomly assigned to treatment and control groups after the 
induction of experimental periodontitis with ligature wires and Porphyromonas 
gingivalis. After 6 weeks, measurements were taken and labeled as baseline 
periodontitis.  Probing depth at baseline was 3.9 ± 1.1mm.  The treatment group received 
1-TDC as a topical application to the diseased sites, the placebo group received mineral 
oil, and the control group was left untreated.  After another 6 weeks, periodontal 
measurements were taken again. The untreated group and placebo group showed similar 
results with continued progression of disease (probing depth at placebo sites was 6.2 ± 
0.3mm). The 1-TDC treated rabbits demonstrated decreased probing depths (3.2 ± 
0.6mm), showing that the progression of periodontitis had been stopped and 
inflammation was decreased.  Radiographic analysis corroborated the macroscopic 
findings and showed that the bone loss was stopped, and actually showed some 
regeneration of the bone.  Sites that were treated with placebo or left untreated showed 
an additional 3% and %5 bone loss, respectively, compared to baseline periodontitis. 
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Clinical Use of Antioxidants in Treatment of Periodontal Disease 
 
 The use of antioxidants as a treatment modality for periodontal disease is a 
developing field.  However, recent clinical trials have shown promising results in their 
ability to reduce inflammation. 
 Chapple et al evaluated the effect of an antioxidant and phytonutrient rich fruit, 
vegetable and berry juice powder versus placebo.43  Sixty volunteers with chronic 
periodontitis and nutritionally replete blood chemistry were enrolled into three groups: 
fruit/vegetable juice powder (FV), fruit/vegetable/berry juice powder (FVB), and 
placebo.  Subjects received non-surgical periodontal therapy, and were asked to take 
daily supplements in addition to their clinical treatment.  Outcome variables were 
evaluated at 2, 5, and 8 months following completion of treatment.  
 Outcomes improved in all groups at two months, with an additional reduction in 
probing depth of 0.22 mm noted in the FV group versus placebo (P<0.03).  Percent 
bleeding on probing was also lower at five months in the FV group versus placebo 
(P<0.05).  The authors concluded that there are initial improvements in probing depth 
and bleeding on probing in patients taking the antioxidant and phytonutrient 
supplements.  However, these were not sustained at the 8 month follow up. 
 Chandra et al evaluated another systemic antioxidant composition in patients 
with gingivitis.44  The antioxidant capsules contained primarily lycopene in addition to 
vitamin A, vitamin C, β-tocopherol acetate, and other antioxidants.  Twenty patients 
were randomized into two groups, one receiving the antioxidant capsules, and the other a 
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placebo.  Across both groups the patients were further randomized into a split mouth 
design, with each patient receiving two quadrants of oral prophylaxis (OP) immediately 
after baseline measurements were taken. The other two quadrants remained untreated 
(non-OP). Outcome measures were taken at one and two weeks, and included 
subgingival bleeding index (SBI), plaque index (PI), and gingival index (GI). 
 Results showed that all groups demonstrated significant reductions in GI relative 
to baseline at one and two weeks.  The OP-lycopene group showed the greatest 
percentage reduction in GI (30.02±7.17%), which was statistically significant (p<0.05) 
compared to the non-OP placebo (11.94±6.55%) and the OP-placebo group (18.85 ± 
7.29%).  The non-OP-lycopene, with a 24.14 ± 4.81% reduction, was significantly 
different from the non-OP-placebo group. 
 The SBI showed similar results, with all groups showing significant reductions 
from the baseline at one and two weeks.  The OP-lycopene (38.42 ± 9.81%) and OP-
placebo (36.94 ± 11.61%) groups showed the greatest percentage reductions in SBI. 
Additionally the OP-lycopene group showed a significant difference (p<0.05) in 
comparison with the non-OP-placebo group (23.96 ± 12.4%). 
 Based on these results the authors concluded that there may be an additive effect 
using routine oral prophylaxis along with antioxidant treatment.    
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Purpose 
 
 Based on this review of the literature, there is an elevated risk of gingivitis and 
oxidative stress in orthodontic patients.  At this point there are a limited number of 
clinical trials evaluating the use of antioxidants in the treatment of gingivitis, and none 
include orthodontic patients.  There are also no clinical trials evaluating the use of ferulic 
acid or phloretin in the treatment of gingivitis. 
This study is a randomized, double-blinded placebo-controlled clinical trial. Our 
aim is to evaluate the efficacy of a topical gel containing ferulic acid and phloretin, in 
addition to essential oils, in the treatment of gingivitis in orthodontic patients (AO 
ProVantage Dental Gel, Periosciences, Dallas, TX). 
  
 20 
 
CHAPTER II 
BACKGROUND 
 
Gingivitis is among the most common pathologies affecting the population, with 
a reported prevalence of over 50%.1-3 While gingivitis is common in all age groups, 
prevalence increases with age.  Around the time of puberty, the prevalence greatly 
increases, peaking between the ages of 9-14,3, 4 which is important for orthodontists 
considering the high number of adolescents they treat.  Between the ages of 11-17, there 
is a tendency for the prevalence of gingivitis to decrease, followed by an increase 
throughout the adult years; by the sixth decade, prevalence approaches 100%.3  
Gingivitis is associated with poor oral hygiene, and increased mechanical plaque 
retention associated with fixed orthodontic appliances is one of the major reasons for 
higher rates of gingivitis among orthodontic patients.5, 6  More recently, oxidative stress, 
and cytotoxic effects of materials in fixed appliances and bonding agents have been 
implicated as factors causing gingival inflammation.7-10   
Several modalities are available for treating gingivitis, including proper oral 
hygiene instructions, various dentifrices, and mouthwashes.11, 12  While essential oil 
mouth rinses provide effective therapy, the current gold standard is use of chlorhexidine 
mouth rinse.13   There is also a developing body of evidence to suggest that antioxidants 
may be useful in the treatment of gingivitis.14-16  
However, there are a limited number of clinical trials evaluating the use of 
antioxidants in the treatment of gingivitis, and none include orthodontic patients.  These 
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trials have found decreased severity of gingivitis, decreased bleeding on probing, and 
modest reduction in pocket depth.43, 44  There are also no clinical trials evaluating the use 
of ferulic acid or phloretin in the treatment of gingivitis.  As such, the aim of the present 
study is to evaluate the efficacy of a topical gel containing ferulic acid and phloretin, in 
addition to essential oils, in the treatment of gingivitis in orthodontic patients.   
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CHAPTER III 
MATERIALS AND METHODS 
 
The study pertains to 32 patients who were undergoing comprehensive treatment 
at Texas A&M University Baylor College of Dentistry.  Eligible patients had to be 12-65 
years old, and have bonded brackets in both arches from first premolar to first premolar, 
or from second premolar to second premolar when the first premolars had been 
extracted.  Patients also had to exhibit a minimum of 30% bleeding on probing at 
qualifying sites, including all bonded teeth mesial to the first molars, and not adjacent to 
a fully banded tooth.   
 Exclusion criteria included patients with syndromes, patients with systemic 
diseases that may contribute to inflammatory processes (such as lichen planus, systemic 
lupus erythematosus, and benign mucus membrane pemphigoid disesase), pregnancy, 
active caries, and periodontally compromised teeth.  Before enrollment, informed 
consent to participate was obtained from each patient; the study was approved by the 
Institutional Review Board at the Texas A&M University Baylor College of Dentistry. 
The study was double-blinded and placebo controlled.  Upon enrollment, patients 
were randomly assigned to either a placebo-controlled group or an active treatment 
group based on a pre-determined randomly generated list. The treatment group contained 
7 males (16.1 ± 1.1 years of age) and 8 females (15.9 ± 2.2 years of age), and the 
placebo group contained 7 males (16.8 ± 2.1 of age) and 8 females (15.1 ± 1.9 years of 
age).  The active treatment group received a gel containing the antioxidants phloretin 
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and ferulic acid, in addition to essential oils (AO ProVantage Dental Gel, Periosciences, 
Dallas, TX).  The placebo gel contained neither the antioxidants nor essential oils.   
All of the patients were instructed, and shown how to apply a pea-sized amount 
of gel to their gingiva twice a day, immediately after brushing.  The gel was applied to 
their buccal and lingual/palatal gingiva.  They were then instructed to thoroughly 
expectorate after 30 seconds, and to avoid rinsing, eating or drinking for 30 minutes. 
Patients were instructed to continue this regimen twice a day until their next regularly 
scheduled orthodontic treatment visit (most approximately 4 to 6 weeks).  
At the initial visit (T1), each patient received a periodontal examination, which 
included probing depths (PD), bleeding on probing (BOP), plaque index45 (PI), and 
gingival index45 (GI).  Each patient also received oral hygiene instructions; tooth 
brushing was demonstrated using the bass technique,46 which was modified to clean both 
gingival and occlusal to the brackets.  Flossing was demonstrated using floss threaders 
(Gum Eez-Thru, Sunstar Americas Inc, Chicago, IL).   
 At the patients’ next regularly scheduled visit (T2), they received another 
periodontal examination, and were instructed to discontinue use of the gel, but to 
continue with a proper oral hygiene regimen until their next visit. At the follow-up visit 
(T3), each patient again received a periodontal examination (Figure 1).  
 The interval from T1 to T2 in the treatment and control groups were 35.7 ± 10.8 
days and 42.6 ± 23.5 days, respectively.  The entire study period, from T1 to T3 was 
78.3 ± 29.5 days for the treatment group, and 92.8 ± 33.9 days for the control group.  
The variability in duration was due to differences in orthodontic treatment intervals and 
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missed appointments.  There were no statistically significant group differences in 
duration between T1 and T2 (p=0.775) or between T2 and T3 (p=0.239).  Based on the 
experimental gingivitis model, these intervals are judged to be sufficient for both the 
resolution, and development of gingivitis.47 
 
Analysis 
 
Each periodontal exam was performed by a single investigator using a UNC 
periodontal probe and #5 explorer (Hu-Friedy, Chicago, IL).  PD was recorded at six 
sites (distobuccal, facial, mesiobuccal, distolingual, lingual, mesiolingual) on each tooth.  
After waiting for 30 seconds, BOP was assessed visually at the same sites and recorded 
as present or absent.  GI and PI were recorded using the Silness-Löe plaque and gingival 
indices.45   Probing depth, gingival index, and plaque index were all expressed as 
averages for each tooth, while bleeding on probing was expressed as a percentage of 
sites for each tooth. 
 
Statistics 
 
SPSS version 22 (SPSS Inc.; Chicago, IL) was used to analyze the data, using 
p<0.05 significance level.  Mean and standard deviation were utilized as descriptive 
statistics because the data were normally distributed.  However, due to small sample 
size, the Mann-Whitney U test was used to evaluate differences between the control and 
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treatment groups, and the Wilcoxon signed ranks test was used to evaluate differences 
between time points within the groups.  
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CHAPTER IV 
RESULTS 
 
During the study, one female from the treatment group and one male from the 
control group dropped out.  On the day they were scheduled for their T2 evaluation, both 
of them stated that they no longer wished to continue in the study due to the discomfort 
associated with the periodontal probing.  The data from their T1 evaluations were not 
included in the results. 
 
Bleeding on Probing 
 
 At the initial T1 examination, BOP occurred at 62.9 ± 12.9% and 72.1 ± 10.7% 
of the sites in the treatment and placebo groups, respectively. The group difference was 
statistically significant (p=0.046) (Figure 2) (Table 1).  From T1 to T2, the treatment 
group showed a statistically significant (p=0.002) 13.6 ± 10.2 percentage point reduction 
in BOP compared to a statistically insignificant (p=0.691) 3.0 ± 12.5 percentage point 
reduction in the placebo group, which was a significant (p=0.007) group difference 
(Figure 3) (Table 2). This produced  a statistically significant (p=0.002) group difference 
at T2, with BOP at 49.2 ± 15.7% and 69.1 ± 16.7% of the sites in the treatment and 
placebo groups, respectively.  The treatment group also showed a statistically significant 
(p=0.016) increase  of 13.3 ± 4.4 percentage points in BOP between T2 and T3, while 
the 7.6 ± 15.4 percentage point increase in the control group was not statistically 
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significant (p=0.124).  At T3, 61.2 ± 12.8% of the sites in the treatment group bled, 
compared to 76.2 ± 12.0% of the sites in the placebo group; this difference was 
statistically significant (p=0.008).   
   
Gingival Index 
 
At T1, GI was 1.56 ± 0.14 and 1.68 ± 0.12 in the treatment and control groups 
respectively.  The groups were significantly different (p=0.029) (Figure 4).  From T1 to 
T2 there was a 0.14 ± 0.11 reduction in GI of the treatment group and a 0.07 ± 0.18 
reduction in the control group. The group difference in the reductions that occurred 
approached, but was not statistically significant (p=0.059). However, the changes of the 
treatment group were statistically significant (p=0.002), whereas those of the placebo 
group were not (p=0.182) (Figure 5).  At T2, the GI of the treatment group was 1.42 ± 
0.17 compared to 1.61 ± 0.20 in the control group, which was a statistically significant 
(p=0.006) difference.  Between T2 and T3, the GI of the treatment and control groups 
increased 0.13 ± 0.15 and 0.13 ± 0.20, respectively; the group difference was not 
statistically significant (p=0.789).  The changes within groups were statistically 
significant for both the treatment (p=0.010) and control groups (p=0.048).  At T3, the 
GIs of the treatment and control groups were 1.54 ± 0.14 and 1.74 ± 0.14, respectively, 
representing a significant (p=0.001) group difference. 
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Probing Depth 
 
At T1 the PDs of the treatment and control groups were 2.58 ± 0.16 mm and 2.60 
± 0.21 mm, respectively, with no significant (p=0.663) group difference (Figure 6). 
From T1 to T2 the changes were statistically insignificant between the groups (p=0.443), 
and within the treatment (p=0.570) and control groups (p=0.379). The treatment group 
decreased 0.03 ± 0.15 mm, and the control group increased 0.05 ± 0.16 mm (Figure 7). 
At T2 the PD in the treatment group was 2.54 ± 0.09 mm and 2.65 ± 0.11 mm in the 
control group, which was a statistically significant (p=0.019) difference.  From T2 to T3, 
the treatment group increased 0.08 ± 0.12mm, and the control group decreased 0.0004 ± 
0.105 mm, which were not significantly (p=0.065) different.  However, the increase 
within the treatment group was statistically significant (p=0.033), while the small 
decrease in the control group was not (p>0.999).  At the T3 follow-up visit, the 
difference between groups was not statistically significant (p=0.715); the treatment and 
control groups had PDs of 2.61 ± 0.09 mm, and 2.65 ± 0.13 mm, respectively. 
  
Plaque Index 
 
Initially, the PI was 0.95 ± 0.29 in the treatment group and 1.04 ± 0.36 in the 
control group, with no significant group difference (p=0.431) (Figure 8). From T1 to T2 
the changes were small and statistically insignificant for both the treatment (p=0.427) 
and control (p=0.233) group; the group difference in the changes that occurred was also 
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statistically insignificant (p=0.135) (Figure 9).  At T2, the PI in the treatment group had 
slightly reduced to 0.87 ± 0.24 and the control group had increased to 1.17 ± 0.41, with 
no group difference (p=0.051). From T2 to T3, PI in the treatment and control groups 
increased 0.18 ± 0.25 and decreased 0.01 ± 0.34, respectively, with no statistically 
significant (p=0.234) group difference.  The increase within the treatment group was 
statistically significant (p=0.028) while the decrease within the control group was not 
(p=0.900).  The PI at T3 was 1.05 ± 0.32 in the treatment group and 1.14 ± 0.32 in the 
control group, again with no group difference (p=0.452). 
  
 30 
 
CHAPTER V 
DISCUSSION 
 
Compared to the control group, the treatment group demonstrated decreased 
severity of gingivitis and inflammation.  This is evidenced by a 13.6 percentage point 
(21.6%) reduction in BOP during the T1 to T2 treatment interval, compared to a 3.0 
percentage point (4.1%) reduction in the control group.  Additionally, GI decreased from 
1.56 to 1.42 (8.9%), whereas the GI of the control group decreased only 4.2%, from 1.68 
to 1.61.  The treatment effect was further validated by the subsequent increase in BOP 
and GI that occurred following cessation of treatment (T2-T3).  The reduction in 
gingivitis during treatment may have been due to decreases in inflammatory mediators 
such as TNF-α and various interleukins brought about by the antioxidant component of 
the gel.23, 38  The essential oil component may also be a factor, since it has been shown to 
improve BOP and GI in in-vivo studies.11, 13, 35, 36 
 The treatment group did not show any clinically significant improvement in PD 
compared to the control group.  There was a statistically significant difference between 
the groups at T2, but the difference was only 0.11 mm.  The treatment group also 
showed a statistically significant increase in PD after cessation of the gel use, but the 
increase was only 0.08 mm.  Despite the lack of clinically significant results regarding 
PD, this study does not preclude the possibility that this type of treatment may have a 
positive effect on pocket depth reductions.  It must be remembered that both the 
treatment and control groups began the study with normal probing depths, leaving very 
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little room for reduction of PD.  Chapple et al showed minor gains in clinical attachment 
levels during the initial phases of treatment with a systemic antioxidant treatment.43  
However, this was an adult sample with chronic periodontitis and at least two sites per 
quadrant having greater than 6 mm of attachment loss.    
 Plaque levels did not appear to be affected by treatment with the antioxidant-
essential oil gel.  The active treatment group showed a reduction from 0.95 to 0.87 
(8.4%) from T1 to T2, while the control group increased from 1.04 to 1.17 (17%).  
However, the group difference was small and not statistically significant. There might 
not have been enough power to detect such a small effect.  The lack of plaque reduction 
may also have been due to the plaque retentive nature of orthodontic appliances.6, 21  
While antioxidants have been shown to have an effect on plaque bacteria in-vitro,14, 15 
and essential oil mouth rinse has been shown to reduce plaque in-vivo,13, 48 these effects 
may be nullified during orthodontic treatment.49  This is consistent with findings of  
Tufekci et al22  and Chen et al,29 who showed small, and statistically insignificant, 
increases in PI over 6 months in orthodontic patients utilizing essential oil mouth 
rinses.35, 50  
The reduction in gingival inflammation is clinically significant compared to the 
control group, but it is possible that this study underestimated the possible effect-size of 
treatment with an antioxidant-essential oil gel.  Other studies, using the same GI criteria 
as this study,13, 51-54 and evaluating essential-oil mouth rinses, have shown larger 
reductions in the GI (≈20%) than the present study (8.9%).  The difference could have 
been due to compliance. In the present study, compliance was only evaluated verbally at 
 32 
 
T2, with all patients responding that they used the gel twice a day as instructed, and 
seldom missed an application.  However, estimates of compliance with homecare oral 
hygiene regimens have been reported to range between 68% and 82%.55  It should also 
be noted that in self-reporting, compliance is often over-estimated.56, 57  Use of a written 
reporting system and or periodic reminders to the patients may have increased actual 
compliance,58 and provided a better estimate of the true effect-size in the treatment 
group. 
The oxidative stress,9, 34 cytotoxicity,8, 32 and increased plaque retention6 associated 
with orthodontic appliances may also account for the smaller effect-size in this study 
compared to others. Two recent studies involving essential oil rinse in orthodontic 
patients report conflicting results.  Tufekci et al showed a small, but statistically 
insignificant, increase in their modified gingival index (MGI)59 and bleeding index 
(BI)60 over 6 months,35 while Chen et al showed a 7% reduction in their MGI and a 66% 
reduction in BI.50     
Further efforts also need to be made to determine the effect of the individual 
components of the gel (antioxidants and essential oils).  It is also necessary to make 
direct comparisons to currently accepted treatment modalities for orthodontic patients, 
including essential oil mouth rinses35, 50 and chlorhexidine rinses, which have been 
shown to decrease both PI and GI.13  In the present study, because of the gel’s 
formulation, it is impossible to determine whether the treatment effect was due to the 
antioxidants, the essential oils, or from a possible synergistic effect. 
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 Findings within the literature indicate that patients with generalized gingival 
inflammation are at higher risk for attachment loss17 and white spot lesions31.  Treatment 
with antioxidant-essential oil gel may reduce the risk of attachment loss and white spot 
lesions in these high-risk patients. 
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CHAPTER VI 
CONCLUSIONS 
 
The study showed that topical antioxidant-essential oil gel is an effective means of 
reducing gingival inflammation in orthodontic patients. It reduced BOP and the GI 
approximately 22% (13.6 percentage points) and 9%, respectively, but had little or no 
effect on the PI and PD.  
 
 
 
 35 
 
REFERENCES 
 
 
1. Stamm JW. Epidemiology of gingivitis. J Clin Periodontol 1986;13:360-70. 
 
2. Oliver RC, Brown LJ, Loe H. Periodontal diseases in the United States 
population. J Periodontol 1998;69:269-78. 
 
3. Neville BW. Oral and maxillofacial pathology. St. Louis, Mo.: 
Saunders/Elsevier; 2009. 
 
4. Nakagawa S, Fujii H, Machida Y, Okuda K. A longitudinal study from 
prepuberty to puberty of gingivitis. Correlation between the occurrence of 
Prevotella intermedia and sex hormones. J Clin Periodontol 1994;21:658-65. 
 
5. Zachrisson S, Zachrisson BU. Gingival condition associated with orthodontic 
treatment. Angle Orthod 1972;42:26-34. 
 
6. Alexander SA. Effects of orthodontic attachments on the gingival health of 
permanent second molars. Am J Orthod Dentofacial Orthop 1991;100:337-40. 
 
7. Wei PF, Ho KY, Ho YP, et al. The investigation of glutathione peroxidase, 
lactoferrin, myeloperoxidase and interleukin-1beta in gingival crevicular fluid: 
implications for oxidative stress in human periodontal diseases. J Periodontal Res 
2004;39:287-93. 
 
8. Grimsdottir MR, Hensten-Pettersen A, Kullmann A. Cytotoxic effect of 
orthodontic appliances. Eur J Orthod 1992;14:47-53. 
 
9. Spalj S, Mlacovic Zrinski M, Tudor Spalj V, Ivankovic Buljan Z. In-vitro 
assessment of oxidative stress generated by orthodontic archwires. Am J Orthod 
Dentofacial Orthop 2012;141:583-9. 
 
10. Patel SP, Pradeep AR, Chowdhry S. Crevicular fluid levels of plasma glutathione 
peroxidase (eGPx) in periodontal health and disease. Arch Oral Biol 
2009;54:543-8. 
 
11. Gunsolley JC. A meta-analysis of six-month studies of antiplaque and 
antigingivitis agents. J Am Dent Assoc 2006;137:1649-57. 
 
12. Acharya S, Goyal A, Utreja AK, Mohanty U. Effect of three different 
motivational techniques on oral hygiene and gingival health of patients 
undergoing multibracketed orthodontics. Angle Orthod 2011;81:884-8. 
 36 
 
13. Van Leeuwen MP, Slot DE, Van der Weijden GA. Essential oils compared to 
chlorhexidine with respect to plaque and parameters of gingival inflammation: a 
systematic review. J Periodontol 2011;82:174-94. 
 
14. Sendamangalam V, Kyun-Choi O, Seo Y, Kim D-S. Antimicrobial and 
Antioxidant Activities of Polyphenols against Streptococcus mutans. Free 
Radicals and Antioxidants 2011;1:48-55. 
 
15. Sendamangalam V, Choi OK, Kim D, Seo Y. The anti-biofouling effect of 
polyphenols against Streptococcus mutans. Biofouling 2011;27:13-9. 
 
16. Zdarilova A, Rajnochova Svobodova A, Chytilova K, Simanek V, Ulrichova J. 
Polyphenolic fraction of Lonicera caerulea L. fruits reduces oxidative stress and 
inflammatory markers induced by lipopolysaccharide in gingival fibroblasts. 
Food Chem Toxicol 2010;48:1555-61. 
 
17. Bartold PM, Walsh LJ, Narayanan AS. Molecular and cell biology of the 
gingiva. Periodontol 2000 2000;24:28-55. 
 
18. Kloehn JS, Pfeifer JS. The effect of orthodontic treatment on the periodontium. 
Angle Orthod 1974;44:127-34. 
 
19. Russell AL. A system of classification and scoring for prevalence surveys of 
periodontal disease. J Dent Res 1956;35:350-9. 
 
20. Greene JC, Vermillion JR. The Simplified Oral Hygiene Index. J Am Dent Assoc 
1964;68:7-13. 
 
21. Naranjo AA, Trivino ML, Jaramillo A, Betancourth M, Botero JE. Changes in 
the subgingival microbiota and periodontal parameters before and 3 months after 
bracket placement. Am J Orthod Dentofacial Orthop 2006;130:275 e17-22. 
 
22. Kim SH, Choi DS, Jang I, et al. Microbiologic changes in subgingival plaque 
before and during the early period of orthodontic treatment. Angle Orthod 
2012;82:254-60. 
 
23. Chapple IL. Reactive oxygen species and antioxidants in inflammatory diseases. 
J Clin Periodontol 1997;24:287-96. 
 
24. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower 
antioxidant capacity in whole saliva and evidence of increased protein oxidation. 
Clin Sci (Lond) 2003;105:167-72. 
 
 37 
 
25. Sanders NL. Evidence-based care in orthodontics and periodontics: a review of 
the literature. J Am Dent Assoc 1999;130:521-7. 
 
26. Wennstrom JL, Stokland BL, Nyman S, Thilander B. Periodontal tissue response 
to orthodontic movement of teeth with infrabony pockets. Am J Orthod 
Dentofacial Orthop 1993;103:313-9. 
 
27. Thilander B. Infrabony pockets and reduced alveolar bone height in relation to 
orthodontic therapy. Semin Orthod 1996;2:55-61. 
 
28. Palomo L, Palomo JM, Bissada NF. Salient Periodontal Issues for the Modern 
Biologic Orthodontist. Seminars in Orthodontics 2008;14:229-45. 
 
29. Zachrisson BU, Alnaes L. Periodontal condition in orthodontically treated and 
untreated individuals. I. Loss of attachment, gingival pocket depth and clinical 
crown height. Angle Orthod 1973;43:402-11. 
 
30. Rateitschak KH, Herzog-Specht F, Hotz R. [Reaction and regeneration of the 
periodontium following treatment with fixed appliances and with removable 
plates]. Fortschr Kieferorthop 1968;29:415-35. 
 
31. Tanner AC, Sonis AL, Lif Holgerson P, et al. White-spot lesions and gingivitis 
microbiotas in orthodontic patients. J Dent Res 2012;91:853-8. 
 
32. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med 
Chem 2005;12:1161-208. 
 
33. Tsaousi A, Jones E, Case CP. The in vitro genotoxicity of orthopaedic ceramic 
(Al2O3) and metal (CoCr alloy) particles. Mutat Res 2010;697:1-9. 
 
34. Buljan ZI, Ribaric SP, Abram M, Ivankovic A, Spalj S. In vitro oxidative stress 
induced by conventional and self-ligating brackets. Angle Orthod 2012;82:340-5. 
 
35. Tufekci E, Casagrande ZA, Lindauer SJ, Fowler CE, Williams KT. Effectiveness 
of an essential oil mouthrinse in improving oral health in orthodontic patients. 
Angle Orthod 2008;78:294-8. 
 
36. Gunsolley JC. Clinical efficacy of antimicrobial mouthrinses. J Dent 2010;38 
Suppl 1:S6-10. 
 
37. Srinivasan M, Sudheer AR, Menon VP. Ferulic Acid: therapeutic potential 
through its antioxidant property. J Clin Biochem Nutr 2007;40:92-100. 
 
 38 
 
38. Jung M, Triebel S, Anke T, Richling E, Erkel G. Influence of apple polyphenols 
on inflammatory gene expression. Mol Nutr Food Res 2009;53:1263-80. 
 
39. Ou L, Kong LY, Zhang XM, Niwa M. Oxidation of ferulic acid by Momordica 
charantia peroxidase and related anti-inflammation activity changes. Biol Pharm 
Bull 2003;26:1511-6. 
 
40. Reaven P. Dietary and pharmacologic regimens to reduce lipid peroxidation in 
non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1995;62:1483S-89S. 
 
41. Jia R, Kurita-Ochiai T, Oguchi S, Yamamoto M. Periodontal Pathogen 
Accelerates Lipid Peroxidation and Atherosclerosis. J Dent Res 2013. 
 
42. Hasturk H, Goguet-Surmenian E, Blackwood A, Andry C, Kantarci A. 1-
Tetradecanol complex: therapeutic actions in experimental periodontitis. J 
Periodontol 2009;80:1103-13. 
 
43. Chapple IL, Milward MR, Ling-Mountford N, et al. Adjunctive daily 
supplementation with encapsulated fruit, vegetable and berry juice powder 
concentrates and clinical periodontal outcomes: a double-blind RCT. J Clin 
Periodontol 2012;39:62-72. 
 
44. Chandra RV, Prabhuji ML, Roopa DA, Ravirajan S, Kishore HC. Efficacy of 
lycopene in the treatment of gingivitis: a randomised, placebo-controlled clinical 
trial. Oral Health Prev Dent 2007;5:327-36. 
 
45. Loe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J 
Periodontol 1967;38:Suppl:610-6. 
 
46. Robinson E. A comparative evaluation of the scrub and Bass methods of 
toothbrushing with flossing as an adjunct (in fifth and sixth graders). Am J Public 
Health 1976;66:1078-81. 
 
47. Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 
1965;36:177-87. 
 
48. Fine DH, Markowitz K, Furgang D, et al. Effect of an essential oil-containing 
antimicrobial mouthrinse on specific plaque bacteria in vivo. J Clin Periodontol 
2007;34:652-7. 
 
49. Rosenbloom RG, Tinanoff N. Salivary Streptococcus mutans levels in patients 
before, during, and after orthodontic treatment. Am J Orthod Dentofacial Orthop 
1991;100:35-7. 
 39 
 
50. Chen Y, Wong RW, Seneviratne CJ, et al. The effects of natural compounds-
containing mouthrinses on patients with fixed orthodontic appliance treatment: 
clinical and microbiological outcomes. Int J Paediatr Dent 2013;23:452-9. 
 
51. Haffajee AD, Roberts C, Murray L, et al. Effect of herbal, essential oil, and 
chlorhexidine mouthrinses on the composition of the subgingival microbiota and 
clinical periodontal parameters. J Clin Dent 2009;20:211-7. 
 
52. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and 
antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-
month clinical trial. J Clin Periodontol 2004;31:878-84. 
 
53. Grossman E, Meckel AH, Isaacs RL, et al. A clinical comparison of antibacterial 
mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental 
plaque and gingivitis. J Periodontol 1989;60:435-40. 
 
54. Axelsson P, Lindhe J. Efficacy of mouthrinses in inhibiting dental plaque and 
gingivitis in man. J Clin Periodontol 1987;14:205-12. 
 
55. Bakdash B. Current patterns of oral hygiene product use and practices. 
Periodontol 2000 1995;8:11-4. 
 
56. Ramsay DS. Patient compliance with oral hygiene regimens: a behavioural self-
regulation analysis with implications for technology. Int Dent J 2000;Suppl 
Creating A Successful:304-11. 
 
57. Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does 
not correspond with electronic monitoring: an evaluation using isosorbide 
dinitrate as a model drug. Pharmacotherapy 1997;17:126-32. 
 
58. McGlynn FD, LeCompte EJ, Thomas RG, Courts FJ, Melamed BG. Effects of 
behavioral self-management on oral hygiene adherence among orthodontic 
patients. Am J Orthod Dentofacial Orthop 1987;91:15-21. 
 
59. Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A modified 
gingival index for use in clinical trials. Clin Prev Dent 1986;8:3-6. 
 
60. Saxton CA, van der Ouderaa FJ. The effect of a dentifrice containing zinc citrate 
and Triclosan on developing gingivitis. J Periodontal Res 1989;24:75-80. 
 
 
 
 40 
 
APPENDIX A 
FIGURES 
 
Figure 1.  Patient Flow through the Study from T1 to T3. 
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Figure 2.  Percentage of Sites with Bleeding on Probing. 
Probability of group differences noted for each time point (Mann-Whitney 
U test). 
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Figure 3.  Percentage Point Change in Sites with Bleeding on Probing. 
Probability of group difference noted in black (Mann-Whitney U test); 
probability of difference between time points within a group are noted in 
color (Wilcoxon signed ranks test). 
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Figure 4.  Gingival Index. 
Probability of group differences noted for each time point (Mann-Whitney 
U test). 
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Figure 5.  Change in Gingival Index. 
Probability of group difference noted in black (Mann-Whitney U test); 
probability of difference between time points within a group are noted in 
color (Wilcoxon signed ranks test). 
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Figure 6.  Probing Depth. 
Probability of group differences noted for each time point (Mann-Whitney 
U test). 
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Figure 7.  Change in Probing Depth (mm). 
Probability of group difference noted in black (Mann-Whitney U test); 
probability of difference between time points within a group are noted in 
color (Wilcoxon signed ranks test). 
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Figure 8.  Plaque Index. 
Probability of group differences noted for each time point (Mann-Whitney 
U test). 
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Figure 9.  Change in Plaque Index. 
Probability of group difference noted in black (Mann-Whitney U test); 
probability of difference between time points within a group are noted in 
color (Wilcoxon signed ranks test). 
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APPENDIX B 
TABLES 
 
% Sites with BOP T1 T2 T3 
Treatment 62.9 ± 12.9 49.2 ± 15.7 61.2 ± 9.3 
Control 72.1 ± 10.7 69.1 ± 16.7 76.2 ± 12.0 
P-Value 0.046 0.002 0.008 
 
   
Gingival Index T1 T2 T3 
Treatment 1.56 ± 0.14 1.42 ± 0.17 1.54 ± 0.14 
Control 1.68 ± 0.12 1.61 ± 0.20 1.74 ± 0.14 
P-Value 0.029 0.006 0.001 
 
   
Probing Depth (mm) T1 T2 T3 
Treatment 2.58 ± 0.16 2.54 ± 0.09 2.61 ± 0.13 
Control 2.60 ± 0.21 2.65 ± 0.11 2.66 ± 0.13 
P-Value 0.663 0.019 0.715 
 
   
Plaque Index T1 T2 T3 
Treatment 0.95 ± 0.28 0.87 ± 0.24 1.05 ± 0.32 
Control 1.04 ± 0.36 1.17 ± 0.41 1.14 ± 0.32 
P-Value 0.431 0.051 0.452 
Table 1.  Outcome Variable Data for T1, T2, and T3. 
Probability of group differences provided (Mann-Whitney U test). 
  
 50 
 
Percentage point change in sites with 
BOP 
T1-T2 T2-T3 T1-T3 
Treatment -13.6 ± 10.2 +13.3 ± 14.4 -1.2 ± 8.1 
P-Value for changes within treatment 
group (Wilcoxon) 
0.002 0.016 0.552 
 
   
Control -3.0 ± 12.5 +7.6 ± 15.4 +4.1 ± 9.6  
P-Value for changes within control 
group(Wilcoxon) 
0.691 0.124 0.109 
P-Value for changes between groups 
(Mann-Whitney) 
0.007 0.225 0.139 
 
   
Change in Gingival Index T1-T2 T2-T3 T1-T3 
Treatment -0.14 ± 0.11 +0.13 ± 0.15 -0.02 ± 0.13 
P-Value for changes within treatment 
group (Wilcoxon) 
0.002 0.010 0.694 
 
   
Control -0.07 ± 0.18 +0.13 ± 0.20 +0.06 ± 0.12 
P-Value for changes within control 
group (Wilcoxon) 
0.182 0.048 0.074 
P-Value for changes between groups 
(Mann-Whitney) 
0.059 0.789 0.099 
 
   
Change in Probing Depth (mm) T1-T2 T2-T3 T1-T3 
Treatment -0.03 ± 0.15 +0.08 ± 0.12 +0.04 ± 0.14 
P-Value for changes within treatment 
group (Wilcoxon) 
0.570 0.033 0.279 
 
   
Control +0.05 ± 0.16 0.00 ± 0.10 +0.06 ± 0.15 
P-Value for changes within control 
group (Wilcoxon) 
0.379 > 0.999 0.363 
P-Value for changes between groups 
(Mann-Whitney) 
0.443 0.065 > 0.999 
    
Change in Plaque Index T1-T2 T2-T3 T1-T3 
Treatment -0.08 ± 0.24 +0.18 ± 0.25 +0.07 ± 0.31 
P-Value for changes within treatment 
group (Wilcoxon) 
0.427 0.028 0.463 
 
 
 
 
Control +0.13 ± 0.43 -0.01 ± 0.34 +0.10 ± 0.49 
P-Value for changes within control 
group (Wilcoxon) 
0.233 0.900 0.402 
P-Value for changes between group 
(Mann-Whitney) 
0.135 0.234 0.771 
Table 2.  Outcome Variable Changes between Time Points. 
Probability of group differences (Mann-Whitney U test), and probability of 
differences within a group between time points (Wilcoxon signed ranks 
test) provided. 
